Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Nov;58(5):668–669. doi: 10.1038/bjc.1988.283

Serum hyaluronic acid levels in cancer.

E H Cooper 1, M A Forbes 1
PMCID: PMC2246812  PMID: 2851313

Full text

PDF
668

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ater J. L., Gooch W. M., 3rd, Bybee B. L., O'Brien R. T. Poor prognosis for mucin-producing Wilms' tumor. Cancer. 1984 Jan 15;53(2):319–323. doi: 10.1002/1097-0142(19840115)53:2<319::aid-cncr2820530224>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  2. Bracey A. W., Wu A. H., Aceves J., Chow T., Carlile S., Hoots W. K. Platelet dysfunction associated with Wilms tumor and hyaluronic acid. Am J Hematol. 1987 Mar;24(3):247–257. doi: 10.1002/ajh.2830240304. [DOI] [PubMed] [Google Scholar]
  3. Broughton P. M., Dykes J. R., Holt S., Ridley J. W., Steel A. E. Mucopolysaccharide in the blood of a patient with neuroblastoma. J Clin Pathol. 1970 Apr;23(3):246–248. doi: 10.1136/jcp.23.3.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Delpech B., Bertrand P., Maingonnat C. Immunoenzymoassay of the hyaluronic acid-hyaluronectin interaction: application to the detection of hyaluronic acid in serum of normal subjects and cancer patients. Anal Biochem. 1985 Sep;149(2):555–565. doi: 10.1016/0003-2697(85)90613-x. [DOI] [PubMed] [Google Scholar]
  5. Engström-Laurent A., Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis. 1985 Feb;44(2):83–88. doi: 10.1136/ard.44.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Engström-Laurent A., Laurent U. B., Lilja K., Laurent T. C. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest. 1985 Oct;45(6):497–504. doi: 10.3109/00365518509155249. [DOI] [PubMed] [Google Scholar]
  7. Engström-Laurent A., Löf L., Nyberg A., Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 1985 Jul-Aug;5(4):638–642. doi: 10.1002/hep.1840050420. [DOI] [PubMed] [Google Scholar]
  8. Frebourg T., Lerebours G., Delpech B., Benhamou D., Bertrand P., Maingonnat C., Boutin C., Nouvet G. Serum hyaluronate in malignant pleural mesothelioma. Cancer. 1987 Jun 15;59(12):2104–2107. doi: 10.1002/1097-0142(19870615)59:12<2104::aid-cncr2820591224>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Hällgren R., Engström-Laurent A., Nisbeth U. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia. Nephron. 1987;46(2):150–154. doi: 10.1159/000184331. [DOI] [PubMed] [Google Scholar]
  10. Laurent U. B., Tengblad A. Determination of hyaluronate in biological samples by a specific radioassay technique. Anal Biochem. 1980 Dec;109(2):386–394. doi: 10.1016/0003-2697(80)90665-x. [DOI] [PubMed] [Google Scholar]
  11. Manley G., Warren C. Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol. 1987 Jun;40(6):626–630. doi: 10.1136/jcp.40.6.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Powars D. R., Allerton S. E., Beierle J., Butler B. B. Wilms' tumor clinical correlation with circulating mucin in three cases. Cancer. 1972 Jun;29(6):1597–1605. doi: 10.1002/1097-0142(197206)29:6<1597::aid-cncr2820290626>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  13. Tengblad A. Quantitative analysis of hyaluronate in nanogram amounts. Biochem J. 1980 Jan 1;185(1):101–105. doi: 10.1042/bj1850101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wu A. H., Parker O. S., Ford L. Hyperviscosity caused by hyaluronic acid in serum in a case of Wilms' tumor. Clin Chem. 1984 Jun;30(6):914–916. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES